- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
After Fraud, Korean Cloner Seeks Redemption
15 January 2014 11:30 am
Woo Suk Hwang shot to fame in early 2004 for two papers in Science offering hope that cloned human stem cells could be used to treat diseases. Within months, the South Korean veterinarian had admitted that data in both papers were fabricated, and he was dismissed from his university post. Hwang is now staging a comeback in animal cloning—the field he started out in before his fall from grace.
For the full story, see this week's issue of Science.